Two-wavelength MAD phasing
Transcription
Two-wavelength MAD phasing
Two-wavelength MAD phasing A. González, J.-D. Pédelacq1, M. Solà2, F. X. Gomis-Rüth 2, M. Coll2 , J.-P. Samama1 , S. Benini European Molecular Biology Laboratory (EMBL), Hamburg Outstation, Notkestrasse 85, 22603 Hamburg, Germany. 1 Groupe de Cristallographie Biologique, Institut de Pharmacologie et de Biologie Structurale du CNRS, 205 route de Narbonne, 31077 Toulouse, France. 2Centre d’Investigació i Desenvolupament, CSIC, Jordi Girona 18-26, 08034 Barcelona, Spain. Project Number:508 EMBL Hamburg beam line(s) X31 and BW7A The Multiwavelength Anomalous Dispersion (MAD) method is being increasingly used to determine protein crystal structures. In theory, data collection at two wavelengths is enough to determine MAD phases, but most often three or even more wavelengths are used. In this experiment we analyzed the results of the phasing procedure using only two wavelengths for the phase determination of several proteins containing different types of anomalous scatterers. In these cases, this approach leads to interpretable maps, not substantially inferior in quality to those obtained with data from three wavelengths, provided that the wavelengths are carefully chosen so as to give a big contrast in the real part of the anomalous scattering factor f’. Figure 1: Detail of the 2.1 Å MAD map of the cytochrome c553 calculated with phases from a two-wavelength data set, showing an -helix and the refined model.